Literature DB >> 16819629

Exercise interest and preferences among patients diagnosed with primary brain cancer.

Lee W Jones1, Bebe Guill, Stephen T Keir, Karen Carter, Henry S Friedman, Darell D Bigner, David A Reardon.   

Abstract

GOALS OF THE WORK: The purpose of the present investigation was to examine the interest and exercise preferences of an institution-based sample of brain tumor patients. Secondary aims were to examine potential differences in participant's interest and preferences by exercise behavior and select demographic/medical variables.
MATERIALS AND METHODS: Using a cross-sectional design, 106 brain tumor patients (age range, 32 to 83 years) who received treatment at the Preston Robert Tisch Brain Tumor Center (BTC) at Duke completed a questionnaire that assessed self-reported exercise behavior, exercise interest and preferences during active and off-treatment periods. MAIN
RESULTS: For exercise program preferences, participants were significantly more interested and felt more capable of participating in an exercise program following compared to during adjuvant therapy. Approximately equal proportions of brain tumor patients preferred to exercise at home with their spouse or other family members. These preferences were consistent across both cancer treatment-related time periods. For exercise information preferences, a higher proportion of respondents preferred receiving information via technologically based approaches (i.e., Internet, CD-ROM, and mailed correspondence) compared with more traditional methods (i.e., mail or face-to-face counseling). Chi-square analyses revealed that a small number of exercise program and information preferences were modified by exercise, medical, and demographic variables.
CONCLUSIONS: Brain tumor patients may have unique and varied preferences compared with other cancer populations. Incorporating patient's preferences into rehabilitation programs and clinical exercise investigations may optimize the potential benefits of this modality for patients with neurologic malignancies.

Entities:  

Mesh:

Year:  2006        PMID: 16819629     DOI: 10.1007/s00520-006-0096-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  40 in total

1.  Exercise participation after diagnosis of breast cancer: trends and effects on mood and quality of life.

Authors:  Bernardine M Pinto; Joseph J Trunzo; Philip Reiss; Shang-Ying Shiu
Journal:  Psychooncology       Date:  2002 Sep-Oct       Impact factor: 3.894

2.  Differences in quality of life between non-Hodgkin's lymphoma survivors meeting and not meeting public health exercise guidelines.

Authors:  Jeffrey K H Vallance; Kerry S Courneya; Lee W Jones; Tony Reiman
Journal:  Psychooncology       Date:  2005-11       Impact factor: 3.894

3.  Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas.

Authors:  S-A Yeh; J-T Ho; C-C Lui; Y-J Huang; C-Y Hsiung; E-Y Huang
Journal:  Br J Radiol       Date:  2005-03       Impact factor: 3.039

4.  Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors.

Authors:  Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

Review 5.  Science and society: the communications revolution and cancer control.

Authors:  K Viswanath
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

Review 6.  Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials.

Authors:  Ruud Knols; Neil K Aaronson; Daniel Uebelhart; Jaap Fransen; Geert Aufdemkampe
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

7.  Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.

Authors:  S Grinspoon; C Corcoran; K Parlman; M Costello; D Rosenthal; E Anderson; T Stanley; D Schoenfeld; B Burrows; D Hayden; N Basgoz; A Klibanski
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

8.  Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

Authors:  Christina Hempen; Elisabeth Weiss; Clemens F Hess
Journal:  Support Care Cancer       Date:  2002-02-09       Impact factor: 3.603

9.  Exercise manages fatigue during breast cancer treatment: a randomized controlled trial.

Authors:  Victoria Mock; Constantine Frangakis; Nancy E Davidson; Mary E Ropka; Mary Pickett; Barbara Poniatowski; Kerry J Stewart; Lane Cameron; Kristin Zawacki; Laura J Podewils; Gary Cohen; Ruth McCorkle
Journal:  Psychooncology       Date:  2005-06       Impact factor: 3.894

10.  A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

Authors:  Phyllis M Windsor; Kathleen F Nicol; Joan Potter
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

View more
  29 in total

1.  Physical activity preferences in a population-based sample of kidney cancer survivors.

Authors:  Linda Trinh; Ronald C Plotnikoff; Ryan E Rhodes; Scott North; Kerry S Courneya
Journal:  Support Care Cancer       Date:  2011-09-24       Impact factor: 3.603

2.  Sport participation in colorectal cancer survivors: an unexplored approach to promoting physical activity.

Authors:  Erin L McGowan; Amy E Speed-Andrews; Ryan E Rhodes; Chris M Blanchard; S Nicole Culos-Reed; Christine M Friedenreich; Kerry S Courneya
Journal:  Support Care Cancer       Date:  2012-05-26       Impact factor: 3.603

3.  Factors associated with cancer survivors' selection between two group physical activity programs.

Authors:  Cindy L Carter; Georgiana Onicescu; Kathleen B Cartmell; Katherine R Sterba; James Tomsic; Todd Fox; Erica Dunmeyer; Anthony J Alberg
Journal:  J Cancer Surviv       Date:  2010-07-27       Impact factor: 4.442

4.  Exercise programming and counseling preferences in bladder cancer survivors: a population-based study.

Authors:  Kristina H Karvinen; Kerry S Courneya; Peter Venner; Scott North
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

Review 5.  Promoting a healthy lifestyle among cancer survivors.

Authors:  Wendy Demark-Wahnefried; Lee W Jones
Journal:  Hematol Oncol Clin North Am       Date:  2008-04       Impact factor: 3.722

6.  Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors.

Authors:  Jae Youn Chung; Dong Hoon Lee; Ji-Hye Park; Mi Kyung Lee; Dong-Woo Kang; Jihee Min; Dong-Il Kim; Duck Hyoun Jeong; Nam Kyu Kim; Jeffrey A Meyerhardt; Lee W Jones; Justin Y Jeon
Journal:  Support Care Cancer       Date:  2013-01-06       Impact factor: 3.603

7.  Exercise preferences and associations between fitness parameters, physical activity, and quality of life in high-grade glioma patients.

Authors:  S Nicole Culos-Reed; Heather J Leach; Lauren C Capozzi; Jacob Easaw; Neil Eves; Guillaume Y Millet
Journal:  Support Care Cancer       Date:  2016-12-17       Impact factor: 3.603

8.  Walking ability in patients with glioblastoma: prognostic value of the Berg Balance Scale and the 10 meter walk test.

Authors:  Monique Mesot Liljehult; Lise Buus; Jacob Liljehult; Birthe Krogh Rasmussen
Journal:  J Neurooncol       Date:  2017-07-27       Impact factor: 4.130

9.  Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial.

Authors:  Karin Gehring; Corelien Jj Kloek; Neil K Aaronson; Kasper W Janssen; Lee W Jones; Margriet M Sitskoorn; Martijn M Stuiver
Journal:  Clin Rehabil       Date:  2017-09-08       Impact factor: 3.477

10.  Physical activity interests and preferences in palliative cancer patients.

Authors:  Sonya S Lowe; Sharon M Watanabe; Vickie E Baracos; Kerry S Courneya
Journal:  Support Care Cancer       Date:  2009-11-10       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.